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Abstract
Purpose: Currently, total hip replacement (THR) is
most commonly performed via a posterior or a direct
lateral approach, but the impact of the latter on the in-
vention’s outcome has yet not been quantified.
Methods: We compared the short-term outcome of ce-
mentless THR using the both approaches in a
prospective, randomized controlled trial. 60 patients
with unilateral osteoarthritis were included. Outcome
assessment was performed one day before surgery and
one week, four weeks, six weeks and 12 weeks after
surgery, respectively, using the Harris Hip score as pri-
mary objective.
Results: We found no significant difference in the in-
traindividual Harris Hip Score improvement at the
pre- and three months post-operative assessments be-
tween both treatment groups (p = 0.115). However,
Harris Hip scores and most functional and psychome-
tric secondary endpoints showed a consistent tenden-
cy of a slightly better three months result in patients
implanted via the posterior approach. In contrast a
significant shorter operating time of the direct lateral
approach was recorded (67 minutes versus 76 minutes,
p<0.001).
Conclusion: In our opinion this slightly better short-
term functional outcome after posterior approach is
not clinical relevant. However, to make definitive con-
clusions all clinical relevant factors (i.e. mid- to long-
term function, satisfaction, complication rates and
long-term survival) have to be taken into account.
Level of evidence: I - therapeutic
Key words: Hip replacement, surgical approach, short-
term result, functional result
INTRODUCTION
Many different surgical approaches to the hip joint
have been described. Currently, total hip replacement
(THR) is most commonly performed via a posterior or
a direct lateral approach [5].
The posterior approach is considered to be associ-
ated with less problems regarding gait, since the ab-
ductor muscles are not dissected and damage to the
superior gluteal nerve is very unlikely [1, 7]. However,
cup positioning is often more difficult and increased
rates of dislocation have been reported [16, 20].
Critics of the direct lateral approach suggest that
the violation of the hip abductors may lead to delay in
recovery of abductor strength and late Trendelenburg
gait [9, 18]. The advantage proposed is the good expo-
sure of the acetabulum, facilitating cup positioning
which may decrease rates of dislocation and the de-
creased risk of sciatic nerve injury which is not close
to the operative field.
The relative merits of these approaches have been
widely debated in the orthopedic community. Howev-
er, the limited number of studies as well as the limited
reporting of their outcome measures prevents defini-
tive conclusions to be drawn [12].
We therefore investigated the short-term outcome
of patients undergoing total hip replacement via pos-
terior versus direct lateral surgical approach in a
prospective randomized manner. Our hypothesis was
that the posterior approach would result in superior
functional outcome after THR due to minor violation
of the hip abductors.
PATIENTS AND METHODS
STUDY DESIGN:
A prospective 1:1 randomization scheme was imple-
mented (random numbers were generated by means
of a block permutation algorithm) to allocate a total
of 60 patients onto the treatment alternatives at hand
(posterior versus lateral approach). Outcome assess-
ment was performed one day before surgery and
one week, four weeks, six weeks and 12 weeks
after surgery, respectively, for each study patient. All
assessments and their documentation were done
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PATIENT COHORT
After approval of the study protocol by the local inde-
pendent Ethics Committee, all patients between 45
and 65 years of age, who suffered from unilateral os-
teoarthritis of the hip and were admitted to our de-
partment for a primary cementless THR between Oc-
tober 2003 and February 2006, were screened for study
inclusion. Exclusion criteria were age (older than 65 or
younger than 45 years), known or suspected osteope-
nia or osteoporosis, deep infection or tumor illness of
the hip, rheumatoid arthritis or higher grade develop-
mental dysplasia of the hip (DDH Crowe stage II or
higher), Charnley class B and C patients, previous op-
eration or fracture of the joint, body mass index (BMI)
over 40 kg/m2, psychiatric illness and drug or alcohol
abuse [6, 8]. In addition, all patients who underwent
Arthroplasty with other implants than stemmed THR
(i.e. surface replacement) were excluded.
Written informed consent was obtained from all pa-
tients; patient information included detailed explana-
tion of the two treatment alternatives under investiga-
tion and of the concept of randomization for treat-
ment allocation. Afterwards, the patients were allocated
into the two treatment groups at the day before surgery
by means of a 1:1 block randomization scheme. At the
day before surgery, additional standard patient infor-
mation about details of the surgery at hand was com-
municated to each individual patient by the surgeon.
The treatment groups did not differ in the side of
surgery (16 posterior versus 18 direct lateral approach-
es were done on the right hip) nor in their diagnosis
(posterior group: 15 primary osteoarthritis cases, 12
DDH Crowe stage I, 1 protrusio acetabuli, 1 Perthes
disease and 1 Epiphysiolysis capitis femoris, respec-
tively; direct lateral group: 19 primary osteoarthritis
cases, 7 DDH Crowe stage I, 2 protrusio acetabuli, 1
Perthes disease, 1 AVN, respectively). 70% of the hips
of the posterior group showed a radiographic arthritis
grade 4, 30% showed a grade 3 according to the Kell-
gren and Lawrence scoring system [13]. The direct lat-
erally approached patients were graded 4 in 80% and 3
in 20%, respectively.
The distributions of gender, age and BMI did not
significantly differ between the patients groups: The
posterior group showed a median age of 55 years (47
– 64 years) versus 58 years (46 – 64 years) in the direct
lateral group (Wilcoxon p = 0.227), the samples’ re-
spective fractions of female patients were 53% versus
50% (Fisher p = 0.905) and their median BMI was
28.9 kg/m2 (20 – 38 kg/m2) versus 26.6 kg/m2 (21 –
39 kg/m2, Wilcoxon p = 0.367). 77% of the patients
of the posterior group and 67% of the direct laterally
implanted patients were married, 63% of the patients
in both groups were employed.
PRIMARY OBJECTIVE AND SAMPLE SIZE
CALCULATION
Main clinical outcome measures were pain, function
and range of movement evaluated by means of the
Harris hip rating system (HHS). 11 The primary clini-
cal endpoint of this investigation was defined as the
intraindividual increase at the 12 weeks assessment
versus its preoperative level. Sample size calculation
was based on the assumption of a minimum clinically
relevant difference of 5 points and a standard devia-
tion of 6 points in the HHS total score. A total of 24
patients had to be enrolled per treatment to achieve a
statistical power of at least 80% in detection of the
above mentioned effect size at a 5% statistical signifi-
cance level by means of a two sample t-test. Assuming
a 20% drop out rate a net sample size of 30 patients
per treatment was required.
SECONDARY OBJECTIVES
The Western Ontario and McMaster Universities Os-
teoarthritis Index (WOMAC), the Short Form-36 (SF-
36) questionnaire and patient activity assessed by
means of the Tegner activity score were measured to
provide additional secondary patient-related endpoints
[3, 22, 23]. Both, the WOMAC total score as well as its
constituent sub dimensions (pain, stiffness, daily life
activities) were transformed into a utility estimate with
range between 0 – 100% (optimum rating); the physi-
cal and mental scale estimates derived from the SF-36
interviews were analyzed accordingly.
The total range of motion and leg length discrepan-
cy assessed by means of blocks with different thick-
nesses, which were placed under each patient’s foot
until the pelvis leveled served as additional clinical
outcome measurements.
Early postoperative function was compared at the
7th day after surgery by means of the walking time
over 25m, the highest possible hip flexion in standing
position and the median step length at a 25m gait
course (length of gait course divided through number
of steps).
ADVERSE OUTCOMES
Adverse outcomes were measured by investigation of
the rate of intra- and postoperative complications
(periprosthetic fracture, nerve palsy, wound infection,
deep thrombosis or pulmonary embolism, dislocation)
and the rate of positive Trendelenburg signs.
OPERATIVE DETAILS
Operative details (operative time, blood transfusion,
length of incision) were recorded.
SURGICAL TECHNIQUE
Surgery was performed under general anesthesia by
two experienced surgeons (11 posterior, 10 direct lat-
eral implantations by KPG and 19 posterior, 20 direct
lateral implantations by WCW). Preoperatively, all pa-
tients received one dose of an intravenous cephalo-
sporin.
The posterior approach entailed a curved incision
centered on the greater trochanter in lateral decubitus
position of the patient. The fascia lata was incised in
line of the skin incision and the fibers of the gluteus
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ternal rotators were then detached close to their
femoral insertion leaving one centimeter of muscle tis-
sue of the quadratus femoris at the dorsal aspect of
the greater trochanter for re-attachment. The posterior
hip capsule was incised and preserved. After implanta-
tion, the posterior capsule was re-attached on the
greater trochanter together with the short external ro-
tators and the wound was closed in layers [17].
The direct lateral approach entailed a longitudinal
skin incision centered over the greater trochanter in
supine position. The tractus iliotibialis and the gluteal
fascia were divided in the line of the skin incision. The
anterior part of the gluteus medius and minimus inser-
tion was incised down to the bone, prolonged distally
through the vastus lateralis in a curved line to spare
some tendinous tissue at the greater trochanter for re-
attachment. The anterior hip capsule was excised. Af-
ter implantation, the tendinous tissue was re-attached
at the greater trochanter and the wound was closed in
layers [2, 10].
IMPLANTS
All patients were implanted with a cementless press-fit
cup, cementless straight stem and a 28mm metal-on-
metal (in cases of metal allergy ceramic-on-ceramic)
articulation (Fitmore or Allofit cup, CLS stem, Metasul
or Cerasul bearing, Zimmer Ltd., Warsaw, US). 12
cups, 6 in each group, were fixed additionally with 1 to
3 screws.
POSTOPERATIVE MANAGEMENT
Low molecular heparin (0.2-0.6 ml fraxiparine per day,
weight-adapted, GlaxoSmithKline GmbH, Germany)
was used for thromboprophylaxis until re-mobiliza-
tion, at least for three weeks. 150mg diclophenac per
day was used for two weeks in order to prevent the
formation of heterotopic bone.
Walking training was started on the first postopera-
tive day, with full weight-bearing allowed. All patients
underwent a standardized physiotherapy program until
hospital discharge at the seventh postoperative day.
Following discharge, all patients trained walking un-
der full weight-bearing with two crutches and received
physiotherapy at an individual basis. During the first
four weeks, hip flexion was limited to 90° and forced
internal as well as external rotation was not allowed.
Four weeks after surgery all patients were admitted
to a cooperative rehabilitation department, where they
underwent a standardized rehabilitation program for
three weeks.
RADIOGRAPHIC ANALYSIS
All patients had anteroposterior radiographs of the
pelvis taken pre-, postoperatively and at the three
months recall. Radiographs were studied by an inde-
pendent observer (LS). Component position was ana-
lyzed using the abduction angle of the cup and the
varus-valgus position of the stem. Heterotopic ossifi-
cation was graded according to the Brooker classifica-
tion [4].
STATISTICAL ANALYSIS
All numerical and graphical evaluations were per-
formed by an independent biometrician (F.K.) by
means of the software SPSS (release 12.0 for Win-
dows). Data description was based on medians, mini-
ma and maxima for continuous endpoints and on ab-
solute and relative frequencies for categorical end-
points. The graphical representation of continuous
data was based on nonparametric box whisker plots,
accordingly. The description of intraindividual com-
parisons in continuous endpoints at different assess-
ment times was based on the distribution of intraindi-
vidual differences. For significance evaluation of these
intraindividual comparisons at continuous endpoints,
the Sign test was applied. For the comparison of sub
samples the two sample Wilcoxon test was applied for
continuous endpoints (such as the primary clinical
endpoint) and the Fisher test for categorical end-
points. Results of significance tests were summarized
by means of p-values.
Analysis of the primary research hypothesis of this
investigation was therefore based on the descriptive
comparison of the primary clinical endpoint (HHS in-
crease after 12 weeks) between the posterior and later-
al treatment group as well as on the derivation of a
two-sided Wilcoxon test p-value (as suggested by the
Statistical Analysis Plan of the trial). Note that this
confirmatory analysis strategy deviates from the t-test
assumption introduced into the sample size calcula-
tion: since the occurrence of statistical outliers could
not be excluded during the preparation of the trial’s
statistical analysis plan, the confirmatory analysis di-
rectly focussed on the application of the two sample
Wilcoxon test. Although the latter shows a gradually
smaller statistical power when compared to its two
sample t-test analogue, the more robust handling of
possible outliers was considered as a dominating ad-
vantage.
If further significance tests were performed in the
context of additional exploratory analyses, the result-
ing p-values were not adjusted for multiplicity due to
the exploratory character of these analyses; a p-value




Operative time (cut-suture-time) was significantly
longer in the posterior group (76.5 minutes [59 – 105
min] versus 67 minutes [47 – 87 min], Wilcoxon
p<0.001). The groups did not differ in the incision
length measured three months after surgery (16 cm
[11 – 23 cm] in the posterior group versus 15 cm [11 –
19 cm] direct lateral, Wilcoxon p = 0.339). Postopera-
tive blood transfusion (one unit of 400 ml) was need-
ed in 23% per group.
PRIMARY CLINICAL ENDPOINT
Patients implanted via a posterior approach started
pre-operatively with a median total HHS score of 46
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directly lateral group (median HHS 50 pts. [29 – 76]),
but showed a slightly superior outcome with in median
83 points (68 – 89) versus 77 points (65 – 82) at the
three months recall assessment (Table 1, Fig. 1). How-
ever, the overall HHS of both treatment groups did
not differ significantly at any assessment time (Wilcox-
on p = 0.307 pre-operatively, p = 0.724 at four weeks,
p = 0.618 at six weeks and p = 0.075 after three
months; Table 1).
Median total HHS score profiles increased in both
groups significantly over the observation period (re-
spective sign test p<0.001). Patients in the posterior
group improved by in median 7 points (-5 – 15) dur-
ing the first four weeks, 18 points (8 – 27) during six
weeks and 30 points (20 – 48) during the three
months period (Table 1, Fig. 2). The corresponding
median intraindividual HHS increases in the directly
lateral group were 10 points (-6 – 18), 14 points (3 –
28) and 25 points (-15 – 36). The treatment groups
did not differ significantly at any assessment time
(Wilcoxon p = 0.967, p = 0.451, p = 0.115, respec-
tively; Table 1), in particular the confirmatory re-
search hypothesis of the investigation, which concen-
trated on the three months HHS increase, could not
be confirmed significantly.
Harris Hip sub scores (pain, function and move-
ment) also showed no significant differences between
the treatment groups (for example, respective Wilcox-
on p-values for pain scores were p = 0.378, p = 0.336,
p = 0.492, p = 0.259). However, the groups showed a
slightly different tendency in function improvement:
in the posterior group, the function sub score rose
from in median 28 points (13 – 41) preoperatively over
20 points (13 – 28) after four weeks and 26 points (17
– 33) after six weeks to 36 points (20 – 47) at three
months slightly superiorly in versus 31 points (12 –
39), 18 points (8 – 29), 24 points (17 – 34) and 32
points (14 – 41) in the direct lateral group (Wilcoxon p
= 0.264, p = 0.118, p = 0.650 and p = 0.073, respec-
tively). On the contrary, movement scores and total
range of motion turned out slightly better in the di-
rectly lateral group with median scores of 7, 7, 7
points and 9 points versus 7, 7, 7 and 8 points after
posterior surgery (Wilcoxon p = 0.646, p = 1.000, p =
0.287 and p = 0.071, respectively) and in median 210°
(150° - 260°) versus 190° (145° - 255°, Wilcoxon p =
0.105).
SECONDARY OBJECTIVES
Early postoperative function at the seventh day after
surgery:
Median walking times at the 25m gait course did not
differ between both groups (posterior group: 35 sec-
onds [27 – 57 sec], direct lateral group: 38 sec [28 – 56
sec], Wilcoxon p = 0.361). Patients after posterior
surgery had a slight, but not significantly, larger result-
ing step length of 60 cm (45 – 66 cm) versus 54 cm
(43 – 71 cm) of the patients with a direct lateral ap-
proach (Wilcoxon p = 0.098). While total range of
motion was significantly better after direct lateral im-
plantation (120° [95 – 150°] versus 110° [90 - 145°],
Wilcoxon p = 0.037), active hip flexion in standing po-
sition showed no difference between the groups (pos-
terior group: 70° [25 - 90°], direct lateral group: 70°
[40 - 90°], Wilcoxon p = 0.722).
Western Ontario and McMaster Universities Os-
teoarthritis Index:
Patients in the posterior group had slightly, but not
significantly smaller scores before surgery, and some-
what, but not significantly better results after three
months: Median WOMAC profiles increased in both
groups significantly over the observation period (re-
spective sign test p<0.001) from 38% versus 43% be-
fore surgery over 66% versus 67% four weeks after-
wards, 72% versus 76% six weeks after surgery to 87%
versus 81% in the three months recall. The samples
did not differ significantly at any assessment time
(Wilcoxon p = 0.109, p = 0.961, p = 0.703, p = 0.359,
respectively). Patients in the posterior group intraindi-
vidually improved by in median 28 % (14 – 38%) dur-
ing four weeks, 38 % (26 – 49%) during six weeks, and
49 % (34 – 58%) during three months. In contrast, the
three months improvement in the directly lateral
group was estimated 30% (19 – 47%) in median and
found significantly smaller (Wilcoxon p = 0.007) com-
pared to the three months increase in the posterior
group. The four and six weeks changes after directly
lateral surgery were 15 % (2 – 34%) and 30 % (19 –
47%), respectively.
Concerning the WOMAC sub scores related to
pain, stiffness and daily life activities, the posterior im-
planted patients showed gradually lower scores before
surgery and ended with higher scores in the three
months assessment for each sub dimension (Table 2).
For example the pain sub score rose from 40% before
posterior surgery to 91% three months afterwards ver-
sus an increase from 47% to 88% after direct lateral
surgery (Wilcoxon p = 0.383 and 0.182, respectively).
However, the treatment groups did not differ signifi-
cant in any of the sub scores (Table 2).
Short-Form 36 Questionnaire:
SF-36 mental and physical scales showed no differ-
ences at any assessment point (Table 3): The physical
scale score increased from 26% before to 50% after
posterior surgery and from 28% to 49% after direct
lateral implantation (Wilcoxon p = 0.515 and p =
0.426, respectively), the corresponding mental scale
scores rose from 60% to 78% and from 53% to 69%
(Wilcoxon p = 0.455 and p = 0.439, respectively).
Patient activity:
Patient activity levels according to the Tegner activity
score were preoperatively slightly lower, and three
months afterwards gradually higher in the posterior
group with median increases of 2.5 points versus 1
point after direct lateral approach, but did not signifi-
cantly differ from those in the direct lateral group
(Wilcoxon p = 0.083 ).
Total range of motion:
Three months postoperatively, patients after the direct
lateral approach showed a total range of motion of in
median 210° (150° - 260°) versus 190° (145° - 255°) of
patients in the posterior group (Wilcoxon p = 0.105).
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Table 1. Medians, minima and maxima for the distribution of total HHS scores before and four, six, 12 weeks after posterior
versus direct lateral THA; medians of the respective intraindividual changes’ distributions (post – preoperative); p-values de-
rived from two sample Wilcoxon test at each assessment time, respectively.
total HHS score
approach preoperative four weeks six weeks three months
posterior 46 (29-64) 53 (44-59) 63 (58-77) 83 (68-89)
direct lateral 50 (29-76) 55 (35-72) 62 (44-80) 77 (65-82)
p-value 0.307 0.724 0.618 0.075
change in total HHS score (post – preoperative)
approach four weeks six weeks three months
posterior 7 (-5 ;15) 18 (8 ; 27) 30 (20 ; 48)
direct lateral 10 (-6 ; 18) 14 (3 ; 28) 25 (15 ; 36)
p-value 0.967 0.451 0.115
Table 2. Medians, minima and maxima for the distribution of WOMAC sub scores for pain, stiffness and daily life activities
(range 0 – 100%, 100% = optimum rating) before and four, six, 12 weeks after posterior versus direct lateral approach; p-values
derived from two sample Wilcoxon test at each assessment time, respectively.
WOMAC
sub scores approach preoperative four weeks six weeks three months
[0 – 100%]
p pa ai in n posterior 40 (0-100) 73 (24-100) 80 (36-100) 91 (34-100)
direct lateral 47 (0-80) 78 (0-100) 84 (0-100) 88 (0-100)
p-value 0.383 0.571 0.870 0.182
s st ti if ff fn ne es ss s posterior 38 (0-80) 70 (25-95) 80 (35-100) 85 (30-100)
direct lateral 45 (0-80) 75 (10-100) 80 (20-100) 80 (20-100)
p-value 0.313 0.128 0.827 0.231
d da ai il ly y   a ac ct ti iv vi it ty y posterior 35 (0-67) 63 (14-92) 72 (25-95) 84 (45-97)
direct lateral 47 (0-76) 62 (0-90) 74 (0-96) 81 (0-100)
p-value 0.055 0.799 0.773 0.476
Table 3. Medians, minima and maxima for the distribution of SF-36 physical and mental scale (range 0 – 100%, 100% = opti-
mum rating) before and four, six, 12 weeks after posterior versus direct lateral approach; p-values derived from two sample
Wilcoxon test at each assessment time, respectively.
SF-36 physical scale [range 0 – 100%]
approach preoperative four weeks six weeks three months
posterior 26 (8-64) 36 (13-68) 44 (21-91) 50 (19-92)
direct lateral 28 (9-70) 33 (12-61) 40 (17-70) 49 (14-91)
p-value 0.515 0.359 0.879 0.426
SF-36 mental scale [range 0 – 100%]
approach preoperative four weeks six weeks three months
posterior 60 (22-89) 62 (28-82) 68 (34-89) 78 (20-94)
direct lateral 53 (12-87) 48 (12-86) 54 (22-91) 69 (26-90)
p-value 0.455 0.085 0.175 0.439
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Preoperatively,  50%  of  the  patients  in  both  groups
had no leg length discrepancy. In 40% (posterior ap-
proach) versus 43% (direct lateral approach) a short-
ening of the involved side, ranging between 0.5 – 2 cm
was observed. Three months postoperatively, 27% of
the patients with a posterior approach showed no dis-
crepancy versus 43% of the direct lateral group. 50%
of the patients in the posterior group had a longer leg
(0.5 – 2 cm, one patient [3%] over 2 cm) on the im-
planted  side  versus  43%  in  the  direct  lateral  group.
The occurrence rates of leg length discrepancies did
not statistically differ (Fisher p = 0.363).
ADVERSE OUTCOMES
Complications:
In  each  group  one  non-dislocated  fracture  of  the
greater  trochanter  occurred  intra-operatively  without
further complication under full weight-bearing. Nerve
lesions were not recorded in any of the groups. Two
patients in the direct lateral group developed a superfi-
cial  wound  infection,  which  resolved  spontaneously.
Whereas  none  of  the  direct  laterally  implanted  pa-
tients  developed  a  clinically  diagnosed  deep  vein
thrombosis,  in  two  cases  of  the  posterior  group  a
thrombosis was observed.
Dislocations:
One posteriorly implanted patient dislocated his hip at
the fifth postoperative day. After closed reduction he
was re-mobilized with full weight-bearing without fur-
ther complications.
Trendelenburg Sign:
While 33% of the patients in each group showed posi-
tive or indifferent Trendelenburg signs before surgery,
only 13% of the posteriorly implanted patients did so
at the three months follow-up examination. Patients in
the direct lateral group had at the borderline of signi  fi  -
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Fig.  1. Box  plots  for  the  distribution  of  Harris  Hip
Score profiles four, six and 12 weeks after THA via pos-
terior versus direct lateral approach (horizontals indicate
medians and quartiles, verticals indicate minimum and
maximum observations).
Fig. 2. Box plots for the distribution of intraindividual
Harris Hip Score changes four, six and 12 weeks after
THA via posterior versus direct lateral approach (hori-
zontals indicate medians and quartiles, verticals indicate
minimum and maximum observations).
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burg signs (37%) at the three months recall (Fisher p =
0.072).
RADIOGRAPHIC RESULTS
The median abduction angle of the cup was not sig-
nificantly different between both groups: Posteriorily
implanted hips showed a median abduction angle of
48° (34°-58°) in contrast to 45° (32°-58°) in the direct
lateral group (Wilcoxon p = 0.477). Two stems of the
direct lateral group were graded to be in slight varus.
All other femoral components were graded to be in
neutral position (Fisher p = 0.492).
Heterotopic bone formation. Three months post-
operatively, heterotopic ossification was present in 7%
(each  grade  II)  of  the  patients  with  a  posterior  ap-
proach. In contrast, 30% (27% grade I, 3% grade II)
of the patients with a direct lateral approach showed
heterotopic ossifications (Fisher p = 0.061).
DISCUSSION
Many  different  surgical  approaches  to  the  hip  have
been described. Currently, the principal methods for
THA are the posterior and direct lateral approaches [5,
15].  We  studied  these  since  they  are  the  two  most
commonly performed surgical approaches in our unit
and both provide adequate exposure for implantation.
The relative merits of these approaches are debated,
although no study has conclusively demonstrated an
advantage of one over the other. Many of the trial re-
ports published involved only small numbers of par-
ticipants with limited reporting of outcome measures
and a poor level of methodological rigor [12]. To our
knowledge only Pascarel et al. (1989) randomly com-
pared 63 patients after a posterior approach with 63
patients  after  a  direct  lateral  approach  [19].  They
found  a  lower  dislocation  rate,  but  a  higher  rate  of
gluteal deficiencies (33% versus 17%) with the direct
lateral approach. But hip replacements in their investi-
gation were performed for several reasons (hip frac-
tures, avascular necrosis of the femoral head, DDH
and osteoarthritis as well) and no specific data were
available for patients with osteoarthritis alone.
To the authors’ knowledge this is the first random-
ized controlled trial in osteoarthritis patients with the
hypothesis of a better short-term functional outcome
of THR through the posterior in contrast to the direct
lateral approach.
In general we could not confirm our hypothesis of
a  superior  short-term  functional  improvement  after
posterior surgical approach due to minor violation of
the hip abductors. Despite the strong inclusion criteria
used (only Charnley grade A patients, standardized re-
habilitation), we were not able to show a significant
difference between both approaches in the Harris hip
rating  system,  which  served  as  primary  objective  of
our study. 
As indicated in the Methods section, this investiga-
tion was designed to achieve a statistical power of at
least 80% in the detection of a 5 point difference in
the HHS changes between both treatment groups. The
actual median HHS changes were indeed 30 points af-
ter posterior approach versus 25 points after direct lat-
eral approach, but were complemented by rather unex-
pectedly large interquartile ranges (Fig. 2). Note, that
the sample size calculation does not only involve the
sample difference in median, but also assumptions on
the underlying sample variations, which were underes-
timated during the planning phase of the trial: A sub-
stantial heterogeneity was observed between and with-
in both patient cohorts, which could hardly be consid-
ered during the planning phase of the trial. The latter
might have been caused by varying motivations among
our patients (for example, due to employment or fami-
ly status). Despite randomization patients in the poste-
rior  approach  group  showed  not  significantly  but
somewhat lower pre-operative score levels, what might
have  influenced  the  pre-/postoperative  differences.
Another  bias  might  have  been  introduced  by  the
rather short observation period. Not all patients may
have reached their optimal functional status again after
12 weeks. The authors therefore intend to prolong this
investigation for one additional postoperative year.
However,  most  functional  and  psychometric  end-
points investigated showed a consistent tendency of a
slightly better short-term result in patients implanted
via the posterior approach. This patient group showed
at the border of significance better Harris hip scores
at the three months recall. Additionally, a slightly – al-
though  not  significantly  better  result  could  be  ob-
served in most secondary endpoints (i.e. walking time,
stride length and patient activity) after THR through
the  posterior  approach.  The  improvement  of  the
WOMAC  index  between  preoperative  and  three
months  postoperative  assessments  was  even  signifi-
cantly better in patients with a posterior approach and
this patient group showed less positive Trendelenburg
signs  three  months  postoperatively.  This  outcome
measure was found to slightly favor the posterior ap-
proach as having fewer participants with postoperative
Trendelenburg gait also by other investigators [1, 14,
21]. Damage of the superior gluteal nerve or failure to
re-attach the muscles during direct lateral approach are
debated as possible reasons. In contrast, direct lateral
approach counted with a significant shorter operating
time,  fewer  clinically  relevant  deep  vein  thromboses
and no versus one dislocation. However, the missing
significance in the primary endpoint of our investiga-
tion prevents definite conclusions from being drawn.
Other factors, like patient related factors, experience
of  the  surgeon  and/or  implant  type  may  have  a
greater influence on the result.
In summary, we could not confirm our hypothesis
of a superior short-term functional improvement of
patients implanted with a THR via the posterior versus
the direct lateral surgical approach. The difference be-
tween both patient groups in intraindividual changes
between  pre-  and  three  months  postoperative  HHS,
which served as our primary endpoint, did not reach
statistical significance. We could observe, however, a
consistent  tendency  of  better  functional  results  in
most of functional and psychometric secondary end-
points.  But,  however,  these  findings  are  not  clinical
relevant in our opinion and are contrasted by the sig-
nificant shorter operating time of the direct lateral ap-
proach. To make definitive conclusions all clinical rele-
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vant factors (i.e. mid- to long-term function, satisfac-
tion, complication rates and long-term survival) have
to be taken into account. We intend to prolong our
study for one postoperative year.
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